Home Blood Pressure Registration Study on Community Elderly Population(HOME Study)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 6,000
- 试验地点
- 2
- 主要终点
- All-Cause Mortality
研究概览
简要总结
China is entering an aging society. As the number of elderly population continues to increase, the elderly are facing many social problems that deserve the attention of all sectors of society. Hypertension is one of the common diseases in the elderly population. Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. Home blood pressure monitoring is simple, not only can find hypertension, but also can guide the treatment of patients with hypertension. The purpose of the study is to investigate the association between home blood pressure and adverse outcomes in community elderly population.
详细描述
Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age, and have provided written informed consent to provide home blood pressure monitoring at one or more study visits.
Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •≥65 years old
- •Signed informed consent
- •Life expectancy is greater than 1 year
排除标准
- •<65 years old
- •Unsigned informed consent
结局指标
主要结局
All-Cause Mortality
时间窗: From date of inclusion until the date of death from any cause, assessed up to 1 year
All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.
Cardiovascular Mortality
时间窗: From date of inclusion until the date of death from any cause, assessed up to 1 year
Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).
次要结局
- Secondary outcomes of hypertension(Through study completion, an average of 1 years)
- Secondary outcomes of diabetes(Through study completion, an average of 1 years)
- Secondary outcomes of kidney(Through study completion, an average of 1 years)
- Secondary outcomes of cardiovascular diseases(Through study completion, an average of 1 years)
- Secondary outcomes of cerebrovascular diseases(Through study completion, an average of 1 years)